iShares Genomics Immunology and Healthcare ETF (IDNA): Price and Financial Metrics ETF
IDNA Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $24.65 | 52-week high | $25.70 |
Prev. close | $24.50 | 52-week low | $17.95 |
Day low | $24.30 | Volume | 35,089 |
Day high | $24.65 | Avg. volume | 32,158 |
50-day MA | $24.49 | Dividend yield | 1.14% |
200-day MA | $23.87 |
IDNA Stock Price Chart Interactive Chart >
iShares Genomics Immunology and Healthcare ETF (IDNA) ETF Bio
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
IDNA ETF Info
Issuer | BlackRock iShares |
Expense Ratio | 0.47% |
Underlying Index | NYSE FactSet Global Genomics and Immuno Biopharma Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 139.96M |
Net Asset Value (NAV) | $24.56 |
Options? | Yes |
Total Holdings | 62 |
IDNA Top Holdings
Symbol | Company | % of Total |
EXEL | EXELIXIS INC | 6.14% |
GILD | GILEAD SCIENCES INC | 5.55% |
RVMD | REVOLUTION MEDICINES INC | 5.36% |
INCY | INCYTE CORP | 5.07% |
ROG | ROCHE HOLDING PAR AG | 4.63% |
BNTX | BIONTECH SE ADR | 4.56% |
SNY | SANOFI SA | 4.33% |
SRPT | SAREPTA THERAPEUTICS INC | 4.13% |
IDNA Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
IDNA Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |